Neurofibromatosis 2
Keywords:
нейрофіброматоз 2, центральний нейрофіброматоз, НФ2, нейрофіброматоз 2 типу, двобічний слуховий нейрофіброматозAbstract
A hereditary disease neurofibromatosis 2 is discussed in the review. The genetics and epidemiology are presented. The author represents diagnostic criteria, clinical signs, and methods of verification of the disease. Strategy of treatment is shown. Surgical aspects of treatment are detailed.References
1. Aguiar P.H., Tatagiba M., Samii M. et al. The comparison between the growth fraction of bilateral vestibular schwannomas in neurofibromatosis 2 (NF2) and unilateral vestibular schwannomas using the monoclonal antibody MIB1 //Acta Neurochir.—1995.—V.134. — P.40—45.
2. Allen J., Eldridge R., Koerber T. Acoustic neuroma in the last months of pregnancy //Amer. J. Obstet. Gynecol.—1974.—V.119. — P.516—520.
3. Bance M., Ramsden R.T. Management of Neurofibromatosis Type 2 //Ear Nose Throat J.—1999.—V.78,N2. — P.91—96.
4. Barker D., Wright E., Nguyen K. et al. Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17 //Science.—1987.—V.236.—P.1098—1102.
5. Baser M., MacCollin M., Sujansky E. et al. Malignant nervous system tumors in patients with neurofibromatosis 2 //Presented at the 1996 FASEB Summer Research Conference on Neurofibromatosis. — Snowmass, Colo, 1996.
6. Black F.O., Brackmann D.E., Hitselberger W.E., Purdy J. Preservation of auditory and vestibular function after surgical removal of bilateral vestibular schwannomas in patient with neurofibromatosis type 2 //Amer. J. Otol.—1995.—V.16.—P.431—443.
7. Blomstedt G.C., Jääskeläinen J.E., Pyykkö I. et al. Recovery of the sutured fascial nerve after removal of acoustic neuroma in patients with neurofibromatosis 2 //Neurosurgery.—1994.—V.35,N3.—P.364—369.
8. Briggs R.J.S., Brackmann D.E., Baser M.E., Hitselberger W.E. Comprehensive management of bilateral acoustic neuromas. Current perspectives //Arch. Otolaryngol. Head Neck Surg.—1994.—V.120.—P.1307—1314.
9. Cushing H. Tumors of the nervus acusticus. — Philadelphia: W.B.Saunders, 1917.
10. Ebersold M.J. Harner S.G., Beatty C.W. et al. Current results of the retrosigmoid approach to acoustic neurinoma //J. Neurosurg.—1992.—V.76.—P.901—909.
11. Eldridge R. Central neurofibromatosis with bilateral acoustic neuroma //Adv.Neurol.—1981.—V.29.—P.57—65.
12. Epstein F.J., Farmer J.P., Freed D. Adult intramedullary spinal cord ependymomas: the result of surgery in 38 patients //J. Neurosurg.—1993.—V.79. — P.204—209.
13. Evans D.G. Neurofibromatosis type 2: genetic and clinical features //Ear Nose Throat J.—1999.—V.78,N2.—P.97—100.
14. Evans D.G., Blair V., Strachan T. et al. Variation of expression of the gene for type 2 neurofibromatosis: absence of a gender effect on vestibular schwannomas, but confirmation of a preponderance of meningiomas in females //J. Laryngol. Otol.—1995.—V.109,N9.—P.830—835.
15. Evans D.G., Huson S.M., Donnai D. et al. A clinical study of type 2 neurofibromatosis //Q. J. Med.—1992.—V.304.—P.603—618.
16. Evans D.G., Huson S.M., Donnai D. et al. A genetic study of type 2 neurofibromatosis in the United Kingdom, I: prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity //J.Med.Genet.—1992.—V.29.—P.841—846.
17. Gaffney R.J., McShane D.P. Bilateral acoustic neurofibromatosis camouflaged by corticosteroid treatment of sudden sensorineural hearing loss //Ir. J. Med. Sci.—1996.—V.165,N3.—P.151—152.
18. Gillespic J.E. Imaging in neurofibromatosis type 2: screening using magnetic resonance imaging //Ear Nose Throat J.—1999.—V.78,N2.—P.102—109.
19. Gutmann D.H., Wright D.E., Geist R.T., Snider W.D. Expression of the neurofibromatosis 2 (NF2) gene isofarms during rat embryonic development //Hum. Mol. Genet.—1995.—V.4.—P.471—478.
20. Gutmann D.H., Aylsworth A., Carey J.C. et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2 //J.A.M.A.—1997.—V.278,N1.—P.51—57.
21. Higami Y., Shimokawa I., Kishikawa M. et al. Malignant peripheral nerve sheath tumors developing multifocally in the central nervous system in a patient with neurofibromatosis type 2 //Clin. Neuropathol.—1998.—V.17,N2.—P.115—120.
22. Huson S.M., Hughes R.A.C. The neurofibromatoses: a pathogenetic and clinical overview. — London: Chapman & Hall, 1994.
23. Jääskeläinen J., Paetau A., Pyykkö I. et al. Interface between the facial nerve and large acoustic neurinomas. Immunohistochemical study of the cleavage plane in NF2 and non-NF2 cases //J. Neurosurg.—1994.—V.80.—P.541—547.
24. Kasantikul V., Netsky M.G., Glasscock M.C., Hayes J.W. Acoustic neurilemmoma: Clinicoanatomical study of 103 patients //J. Neurosurg.—1980.—V.52.—P.28—35.
25. King T.T., Sparrow O.C., Arias J.M., O’Connor A.F. Repair of facial nerve after removal of cerebellopontine angle tumors: A comparative study //J. Neurosurg.—1993.—V.78.—P.720—725.
26. Klekamp J., Samii M. Surgery of spinal nerve sheath tumors with special reference to neurofibromatosis //Neurosurgery.—1998.—V.42,N2.—P.279—290.
27. Linskey M.E., Lunsford L.D., Flickinger J.C. Tumor control after stereotactic radiosurgery in neurofibromatosis patients with bilateral acoustic tumors //Neurosurgery.—1992.—V.31,N5.—P.829—39.
28. Linthicum F.H. Jr, Brackmann D.E. Bilateral acoustic tumors: A diagnostic and surgical challenge //Arch. Otolaryngol.—1980.—V.106.—P.729—733.
29. Lunsford L.D., Linskey M. Stereotactic radiosurgery in the treatment of patients with acoustic tumors //Otol. Clin. N. Amer.—1992.—V.25.—P.471—491.
30. Martuza R.L., Maclaughlin D.T., Ojermann R.G. Specific estradiol binding in schwannomas, meningiomas, and neurofibromas //Neurosurgery.—1981.—V.9.—P.665—671.
31. Mautner V.F., Lindenau M., Baser M.E. et al. The neuroimaging and clinical spectrum of neurofibromatosis 2 //Neurosurgery. —1996. —V.38, N5. — P.880—886.
32. Mautner V.F., Lindenau M., Köppen J. et al.Type 2 neurofibromatosis without acoustic neuroma // Zbl. Neurochir. — 1995. — Bd.56, H2. — S.83—87.
33. Mautner V.F., Tatagiba M., Guthoff R. et al. Neurofibromatosis 2 in the pediatric age group //Neurosurgery.—1993.—V.33, N1.—P.92—96.
34. Mautner V.F., Tatagiba M., Lindenau M. et al. Spinal tumors in patients with neurofibromatosis type 2: MR imaging study of frequency, multiplicity and variety [published erratum appears in Amer. J. Roentgenol. — 1996. — V. 166, N5.—P.1231] //Amer. J. Roentgenol.—1995.—V.165. —P.951—955.
35. McCollin M., Mautner V.F. The diagnosis and management of neurofibromatosis 2 in childhood //Seminars. Pediat. Neurol.—1998.—V.5, N4.—P.243—252.
36. McCormick P.C., Torres R., Post K.D., Stein B.M. Intramedullary ependymoma of the spinal cord //J. Neurosurg. —1990. —V.72. —P.523—532.
37. Meyers S.M., Gutmann F.A., Kaye L.D., Rothner A.D. Retinal changes associated with neurofibromatosis 2 //Trans Amer. Ophthalmol. Soc.—1995.—V.93.—P.245—257.
38. Mulvihill J.J., Parry D.M., Sherman J.L. et al. NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update //Ann. Intern. Med.—1990.—V.113.—P.39—52.
39. Nadol J., Chiong C., Ojemann R. et al. Preservation of hearing and facial nerve function in resection of acoustic neuroma //Laryngoscope.—1992.—V.102.—P.1153—1158.
40. National Institutes of Health Consensus Development Conference. Neurofibromatosis: Conference Statement //Arch. Neurol.—1988.—V.45.—P.575—578.
41. National Institutes of Health Consensus Development Conference Statement on Acoustic Neuroma: December 11—13, 1991 //Arch. Neurol.—1994. —V.51. —P.201—207.
42. Nitta T., Sato K. A clinical study of 21 patients with neurofibromatosis 1 and 2 //No Shinkei Geka. —1995. —V.23, N2. —P.131—135.
43. Ogunrinde O.K., Lunsford L.D., Flickinger J.C., Kondziolka D.S. Cranial nerve preservation after stereotactic radiosurgery for small acoustic tumors //Arch. Neurol.—1995.—V.52.—P.73—79.
44. Ojemann R.G. Management of acoustic neuromas (vestibular schwannomas) //Clin. Neurosurg.—1993.—V.40.—P.489—535.
45. Parry D.M., Eldridge R., Kaiser-Kupfer M.I. et al. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity //Amer. J. Med. Genet.—1994. —V.52.—P.450—461.
46. Pearson-Webb M.A., Kaiser-Kupfer M.I., Eldridge R. Eye findings in bilateral acoustic (central) neurofibromatosis. Association with presenile lens opacities and cataracts but absence of Lisch nodules //New. Engl. J. Med.—1986.—V.315. —P.1553—1554.
47. Ragge N.K., Baser M.E., Klein J. et al. Ocular abnormalities in neurofibromatosis 2 //Amer. J. Ophthalmol.—1995.—V.120.—P.634—641.
48. Rettele G.A., Brodsky M.C., Merin L.M. et al. Blindness, deafness, quadriparesis, and a retinal malformation: the ravages of neurofibromatosis 2 //Surv. Ophthalmol.—1996. —V.41,N2.—P.135—141.
49. Rouleau G.A., Merel P., Lutchman M. et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2 //Nature—1993.—V.363.—P.515—521.
50. Rouleau G.A., Wertelecki W., Haines J.L. et al. Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22 //Nature.—1987.—V.329.—P.246—248.
51. Rubenstein A.E., Korf B.R. Neurofibromatosis: A Handbook For Patients, Families and health-Care Professionals. — Stuttgart: New York: Georg Thieme Verlag,1990.—256 p.
52. Samii M., Matthies C. Management of 1000 vestibular schwannomas (acoustic neuromas): Hearing function in 1000 tumor resections //Neurosurgery. — 1997. —V.40, N2.—P.248—262.
53. Samii M., Matthies C., Tatagiba M. Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2 //Neurosurgery.—1997. — V.40, N4. — P.696—706.
54. Schimmel L.J., Keyser A. Neurofibromatosis type 2 //Ned. Tijdschr. Geneeskd.—1997.—Bd.141, H.13. — S.639—643.
55. Seizinger R.R., Rouleau G.A., Ozelins L.J. et al. Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene //Cell.—1987.—V.49.—P.589—594.
56. Slattery W.H. 3rd, Brackmann D.E., Hitselberger W. Hearing preservation in neurofibromatosis type 2 //Amer. J. Otol.—1998.—V.19,N5.—P.638—643.
57. Sobel R.A. Vestibular (acoustic) schwannomas: histologic features in neurofibromatosis 2 and in unilateral cases //J. Neuropathol. Exp. Neurol.—1993.—V.52.—P.106—113.
58. Tator C.H. Acoustic neuromas: management of 204 cases //Canad. J. Neurol. Sci.—1985.—V.12.—P.353—357.
59. Tonsgard J.H., Oesterle C.S. The ophthalmologic presentation of NF-2 in childhood //J. Pediat. Ophthalmol. Strabismus.—1993.—V.30.—P.327—330.
60. Trofatter J.A., Mac Collin M.M., Rutter J.L. et al. A novel moesin-, ezrin-, radixin- like gene is a candidate for the neurofibromatosis 2 tumors supressor //Cell.—1993.—V.72.—P.791—800.
61. Val Bernal J.F., Figols J., Vözquez Barquero A. Cutaneous plexiform schwannoma associated with neurofibromatosis type 2 //Cancer.—1995.—V.76,N7.—P.1181—1186.
62. Wertelecki W., Rouleau G.A., Superneau D.W. et al. Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred //New Engl. J. Med.—1988.—V.319.—P.278—283.
63. Wiestler O.D., von Siebenthal K., Schmitt H.P. et al. Distribution and immunoreactivity of cerebral micro-hamartomas in bilateral acoustic neurofibromatosis (neurofibromatosis 2) //Acta Neuropathol.—1989.—V.79.—P.137—143.
64. Young D.F., Eldridge R., Nager G.T. et al. Hereditary bilateral acoustic neuroma (central neurofibromatosis) //Birt. Defects.—1971.—V.7.—P.73—86.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2002 M. V. Kvasnitsky
This work is licensed under a Creative Commons Attribution 4.0 International License.
Ukrainian Neurosurgical Journal abides by the CREATIVE COMMONS copyright rights and permissions for open access journals.
Authors, who are published in this Journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the Journal under the terms of Creative Commons Attribution License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this Journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form of which it has been published by the Journal (for example, to upload the work to the online storage of the Journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this Journal is included.
